Weekly gemcitabine and cisplatin concurrent with pelvic irradiation for primary therapy of cervical cancer: Report of the first seven cases in Thai women

Radiation Medicine - Medical Imaging and Radiation Oncology

Volumn 25, Issue 9, 2007, Pages 474-479

  Chumworathayi, Bandit ^a   Yuenyao, Pissamai ^a   Tangvorapongchai, Vorachai ^a   Luanratanakorn, Sanguanchoke ^a   Pattamadilok, Jeerichuda ^a   Krusun, Srichai ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Cervical cancer; Cisplatin; Concurrent chemoradiation; Gemcitabine

Indexed keywords

CISPLATIN; GEMCITABINE; GRANULOCYTE COLONY STIMULATING FACTOR; PLACIS; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; DRUG DERIVATIVE;

ADULT; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FATIGUE; FEMALE; FOLLOW UP; HUMAN; IRRADIATION; NAUSEA; NEUTROPHIL; RADIATION DOSE; SIDE EFFECT; THAILAND; UTERINE CERVIX CANCER; BRACHYTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UTERINE CERVIX TUMOR;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; CISPLATIN; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MIDDLE AGED; THAILAND; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 39549098747     PISSN: 02882043     EISSN: 18625274     Source Type: Journal    
DOI: 10.1007/s11604-007-0171-1     Document Type: Article

References (27)

1. S Basile R Angioli N Manci I Palaia F Plotti P Benedetti Panici 2006 Gynecological cancers in developing countries: the challenge of chemotherapy in low-resources setting Int J Gynecol Cancer 16 1491 7
2. US Dept. of Health and Human Services. NCI Clinical announcement. Bethesda, MD: Public Health Service, National Institutes of Health; 1999
3. CW Whitney W Sause BN Bundy JH Malfetano EV Hannigan WC Fowler 1999 A randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study J Clin Oncol 17 1339 48
4. M Morris PJ Eifel J Lu PW Grigsby C Levenback RE Stevens 1999 Pelvic radiation with concurrent chemotherapy versus pelvic and para-aortic radiation for high risk cervical cancer: a randomized Radiation Therapy Oncology Group clinical trial N Engl J Med 340 1137 43
5. PG Rose BN Bundy EB Watkins JT Thigpen G Deppe MA Maiman 1999 Concurrent cisplatin-based chemoradiation improves progression free and overall survival in advanced cervical cancer: results of a randomized Gynecologic Oncology Group study N Engl J Med 340 1144 53
6. HM Keys BN Bundy FB Stehman LI Muderspach WE Chafe CL Suggs III 1999 A comparison of weekly cisplatin during radiation therapy versus irradiation alone, each follow by adjuvant hysterectomy in bulky stage IB cervical carcinoma: a randomized trial of the Gynecologic Oncology Group N Engl J Med 340 1154 61
7. WA Peters III PY Liu RJ Barrett RJ Stock BJ Monk JS Berek 2000 Cisplatin and 5-flourouracil plus radiation therapy are superior to radiation therapy as adjunctive in high-risk early stage carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: report of a phase II intergroup study J Clin Oncol 18 1606 13
8. PG Rose 2002 Chemoradiotherapy for cervical cancer Eur J Cancer 38 207 8
9. TK Park SN Kim SW Kim GE Kim CO Suh 2000 Concurrent chemotherapy and radiotherapy in invasive cervical cancer patients with high risk factors J Korean Med Sci 15 436 41
10. MA Killackey L Boardman DS Carroll 1993 Adjuvant chemotherapy and radiation in patients with poor prognosis stage IB-IIA cervical cancer Gynecol Oncol 49 377 9
11. GM Thomas AJ Dembo T Myhr B Black JF Pringle G Rawling 1993 Long-term results of concurrent radiation and chemotherapy for carcinoma of the cervix recurrent after surgery Int J Gynecol Cancer 3 193 8
12. R Pearcey M Brundage P Drouin J Jeffrey D Johnston H Lukka 2002 Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix J Clin Oncol 20 966 72
13. B Chumworathayi P Suprasert K Charoenkwan J Srisomboon C Phongnarisorn S Siriaree 2005 Weekly versus three-weekly cisplatin as an adjunct to radiation therapy in high-risk stage I-IIA cervical cancer after surgery: a randomized comparison of treatment compliance J Med Assoc Thai 88 1483 92
14. Tangsiriwatthana T, Chumworathayi B, Yuenyao P, Luanratanakorn S, Pattamadilok J. Srinagarind Hospital experience in concurrent chemoradiation for 100 patients with stage IB2-IVA uterine cervical cancer. Radiat Med 2007;25 (in press)
15. P Pattaranutaporn C Thirapakawong Y Chansilpa S Therasakvichya N Ieumwananontachai K Thepamongkhol 2001 Phase II study of concurrent gemcitabine and radiotherapy in locally advanced stage IIIB cervical carcinoma Gynecol Oncol 81 404 7
16. Deerasamee S, Srivatanakul P. Cervix uteri. In: Deerasamee S, Martin N, Sontipong S, Sriamporn S, Sriplung S, Srivatanakul P, et al, editors. Cancer in Thailand. Vol II. 1992-1994. Lyon: IARC; 1999. p. 56-9
17. A Duenas-Gonzalez L Cetina-Perez C Lopez-Graniel A Gonzalez-Enciso E Gomez-Gonzalez L Rivera-Rubi 2005 Pathologic response and toxicity assessment of chemoradiotherapy with cisplatin versus cisplatin plus gemcitabine in cervical cancer: a randomized phase II study Int J Radiat Oncol Biol Phys 61 817 23
18. J Umanzor M Aguiluz C Pineda S Andrade M Erazo 2003 Concurrent chemoradiation in locally advanced cervical carcinoma (LACC): role of a combination of cisplatin, gemcitabine and radiotherapy-a phase II trial Proc Am Soc Clin Oncol 22 486
19. JJ Zarba AV Jaremtchuk PG Jazey M Keropian R Castagnino C Mina 2003 A phase I-II study of weekly cisplatin and gemcitabine with concurrent radiotherapy in locally advanced cervical carcinoma Ann Oncol 14 1285 90
20. Cancer Therapy Evaluation Program. Common Terminology Criteria for Adverse Events, Version 3.0. DCTD, NCI, NIH, DHHS March 31, 2003 (http://ctep.cancer.gov), Published August 9, 2006.
21. Deerasamee S, Srivatanakul P. Cervix uteri. In: Deerasamee S, Martin N, Sontipong S, Sriamporn S, Sriplung S, Srivatanakul P, et al, editors. Cancer in Thailand. Vol II. 1992-1994. Lyon: IARC; 1999. p. 45-8
22. EM Swisher RE Swensen B Greer H Tamimi BA Goff R Garcia 2006 Weekly gemcitabine and cisplatin in combination with pelvic radiation in the primary therapy of cervical cancer: a phase I trial of the Puget Sound Oncology Consortium Gynecol Oncol 101 429 35
23. R Pearcey M Brundage P Drouin J Jeffrey D Johnston H Lukka 2002 Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix J Clin Oncol 20 966 72
24. K Serkies J Jassem 2004 Concurrent weekly cisplatin and radiotherapy in routine management of cervical cancer: a report on patient compliance and acute toxicity Int J Radiat Oncol Biol Phys 60 814 21
25. P Yuenyao B Chumworathayi S Luanratanakorn M Wongsena P Soopa-atakon T Chotanaprasit 2007 Hematologic toxicities of cisplatin concurrent chemoradiation in cervical cancer at Ubonrajchathani Cancer Center Srinagarind Med J 22 127 32
26. MA Moufarij DR Phillips C Cullinane 2003 Gemcitabine potentiates cisplatin cytotoxicity and inhibits repair of cisplatin-DNA damage in ovarian cancer cell lines Mol Pharmacol 63 862 9
27. K Ohara YO Tanaka H Tsunoda A Oki T Satoh K Onishi 2005 Preliminary estimation of treatment effect on uterine cervical squamous cell carcinoma in terms of tumor regression rate: comparison between chemoradiotherapy and radiotherapy alone Radiat Med 23 25 9